Effectiveness of transdermal oestradiol and natural micronised progesterone for menopausal symptoms

Br J Gen Pract. 2018 Oct;68(675):499-500. doi: 10.3399/bjgp18X699353.
No abstract available

Publication types

  • Comment

MeSH terms

  • Administration, Cutaneous
  • Estradiol*
  • Estrogens
  • Female
  • Humans
  • Postmenopause
  • Progesterone*
  • Progestins
  • Risk Assessment
  • Women's Health

Substances

  • Estrogens
  • Progestins
  • Progesterone
  • Estradiol